[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369329-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369329-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-comprehensive-analysis-of-epoxide-hydrolase-2-ephx2-in-pan-cancer","A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan-Cancer","","Epoxide hydrolase 2 (EPHX2) modulates lipid signaling through soluble epoxide hydrolase, yet its roles in human malignancies and clinical outcomes are unclear. This study mapped the prognostic landscape of EPHX2 across pan-cancer and examined associations with immune infiltration in the tumor microenvironment. Multiple bioinformatics tools assessed EPHX2 expression, diagnostic and prognostic relevance, and related signaling pathways using GSVA. TIDE, GDSC, and CTRP predicted immunotherapy response and small-molecule sensitivity, and qPCR validated EPHX2 expression in cancer cell lines.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-comprehensive-analysis-of-epoxide-hydrolase-2-ephx2-in-pan-cancer/369329/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-comprehensive-analysis-of-epoxide-hydrolase-2-ephx2-in-pan-cancer/369329.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this study on EPHX2?","Question",{"text":63,"@type":64},"The study aims to define EPHX2’s prognostic landscape across pan-cancer and evaluate its potential relationship with immune infiltration in the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were EPHX2 expression and its clinical relevance analyzed?",{"text":68,"@type":64},"The research used multiple bioinformatics tools to assess expression, diagnostic value, and prognostic significance of EPHX2, followed by pathway analysis via GSVA.",{"name":70,"@type":61,"acceptedAnswer":71},"How were immunotherapy response and drug sensitivity predictions performed?",{"text":72,"@type":64},"TIDE, GDSC, and CTRP databases were used to predict EPHX2-associated responses to immunotherapy and sensitivity to small-molecule drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369329,1790595870,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nA Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan-Cancer  \nWeiquan Hu1 | Xiaoli Ding2 | Xiangsheng Wu2 | Xuxiang Xi2 | Jing Xu3 | Shengyun Dai4 | Jing Chen2 | Suping Hu5 | Qinfei Zhao2  | Fangfang Chen6,7  \n1Department of Joint Surgery, Ganzhou People's Hospital, Ganzhou, Jiangxi, China | 2Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China | 3Department of Orthopaedic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China | 4National Institutes for Food and Drug Control, Beijing, China | 5Department of Emergency, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China | 6The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong,  \nChina | 7Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China Correspondence: Qinfei Zhao ([m18179976976@163.com](m18179976976@163.com)) | Fangfang Chen ([longysh@163.com](longysh@163.com))  \nReceived: 21 November 2023 | Revised: 28 January 2025 | Accepted: 10 March 2025  \nFunding: This work was supported by the Natural Science Foundation of China (Grant No. 82002233), the Clinical Diagnosis and Treatment New Technology Project (Grant No. 22LCZLXJS58), the “Technology+Medical”-Targeted Project of the First Affiliated Hospital of Gannan Medical University (No. 2023NS326774), the Science and Technology Plan of the Health Commission of Jiangxi Province (No. 202311903), the Jiangxi Traditional Chinese Medicine Science and Technology Program (No. 2022A136), the City-Level Scientific Research Project of the Ganzhou Municipal Health Commission (No. GZWJW202402043), the First Affiliated Hospital of Gannan Medical University's faculty-level project (No. YJYB202013), the General Program of the Jiangxi Administration of Traditional Chinese Medicine (2023A0009), and the Guiding Science and Technology Plan Project of Ganzhou (No. GZ2023ZSF137) .  \nKeywords: EPHX2 | immune checkpoint blockade (ICB) | immune infiltration | immunotherapy | pan-cancer | prognosis  \nABSTRACT  \nBackground and Aims: Epoxide hydrolase 2 (EPHX2) regulates lipid signaling across various metabolites by encoding soluble epoxide hydrolase. However, its mechanisms and implications in human malignancies remain unknown. This research aimed to detail the prognostic landscape of EPHX2 in pan-cancer and explore its potential relationship with immune infiltration in the tumor microenvironment.  \nMethods: Herein, multiple bioinformatics tools were used to comprehensively evaluate the expression, diagnostic, and prognostic significance of EPHX2 and its roles in the tumor immune microenvironment in human cancers. The underlying EPHX2-associated signaling pathways in cancers were investigated by gene set variation analysis (GSVA) . TIDE, GDSC, and CTRP databases were applied to predict the response of EPHX2 to immunotherapy and sensitivity to small molecule drugs. Furthermore, EPHX2 expression was also validated by qPCR experiments in various cancer cell lines.  \n\n| Abbreviations: ACC, adrenocortical carcinoma; AUC, area under the ROC curves; BLCA, bladder urothelial carcinoma; BRCA, breast cancer; CAN, copy number alteration; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; CRC, colorectal cancer; ccRCC, clear cell renal cell carcinoma; CPTAC, clinical proteomic tumor analysis consortium; CTRP, Cancer Therapeutics Response Portal; DSS, disease-specific survival; DFS, disease-free survival; DLBC, lymphoid neoplasm diffuse large B-cell lymphoma; ESCA, esophageal carcinoma; EPHX2, epoxide hydrolase 2; FS, progression-free survival; GBM, glioblastoma multiforme; GEPIA2, gene expression profiling interactive analysis 2; GDSC, Genomics of Drug Sensitivity in Cancer; GSVA, gene set variation analysis; HNSC, head and neck ","cbCaijBGouUimaBh","https://ap.wps.com/l/cbCaijBGouUimaBh","pdf",15568247,23,"English","# Abstract\n## Background and Aims\n## Methods\n## Results","[{\"question\":\"What is the main purpose of this study on EPHX2?\",\"answer\":\"The study aims to define EPHX2’s prognostic landscape across pan-cancer and evaluate its potential relationship with immune infiltration in the tumor microenvironment.\"},{\"question\":\"How were EPHX2 expression and its clinical relevance analyzed?\",\"answer\":\"The research used multiple bioinformatics tools to assess expression, diagnostic value, and prognostic significance of EPHX2, followed by pathway analysis via GSVA.\"},{\"question\":\"How were immunotherapy response and drug sensitivity predictions performed?\",\"answer\":\"TIDE, GDSC, and CTRP databases were used to predict EPHX2-associated responses to immunotherapy and sensitivity to small-molecule drugs.\"}]","A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan-Cancer | PDF",1790182080,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a7b6b517fb683c6ce42421050fda39b.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7f5898a488dca540c69cd355a3de291.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6dab0630022e0b2ed45c7845089af84.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c119a440c003bf8de6593ccfc95cd54.webp",980,1287]